OBJECTIVES: The tumor-suppressor breast cancer susceptibility gene 1 (BRCA1) is a nuclear-cytoplasmic shuttling protein that when in the nucleus is required for DNA repair whereas when in the cytoplasm is important in activating cell death processes. Although BRCA1 mutations have been shown to be associated with an increased risk of pancreatic ductal adenocarcinoma (PDAC), its role in disease progression is yet to be determined. We hypothesized that BRCA1 expression pattern could be used as a prognostic biomarker. METHODS: Sixty-seven patients who underwent resections for PDAC were included. A tissue microarray was constructed, stained with antibodies to BRCA1, and scored for intensity and subcellular location. Univariate and multivariate statistical analyses were performed. RESULTS: An increase in cytosolic BRCA1 distribution was associated with higher pathologic stage (P = 0.006). Nuclear-cytosolic BRCA1 distribution was associated with a decrease in recurrence-free survival with a hazards ratio of 1.4 (P = 0.059). Decreased BRCA1 intensity was associated with higher pathologic stage (P = 0.027), but BRCA1 intensity was not associated with overall survival or recurrence-free survival. CONCLUSIONS: Our results demonstrate a possible association of BRCA1 expression pattern with pathologic stage, implying a potential role of BRCA1 in PDAC development and progression.
OBJECTIVES: The tumor-suppressor breast cancer susceptibility gene 1 (BRCA1) is a nuclear-cytoplasmic shuttling protein that when in the nucleus is required for DNA repair whereas when in the cytoplasm is important in activating cell death processes. Although BRCA1 mutations have been shown to be associated with an increased risk of pancreatic ductal adenocarcinoma (PDAC), its role in disease progression is yet to be determined. We hypothesized that BRCA1 expression pattern could be used as a prognostic biomarker. METHODS: Sixty-seven patients who underwent resections for PDAC were included. A tissue microarray was constructed, stained with antibodies to BRCA1, and scored for intensity and subcellular location. Univariate and multivariate statistical analyses were performed. RESULTS: An increase in cytosolic BRCA1 distribution was associated with higher pathologic stage (P = 0.006). Nuclear-cytosolic BRCA1 distribution was associated with a decrease in recurrence-free survival with a hazards ratio of 1.4 (P = 0.059). Decreased BRCA1 intensity was associated with higher pathologic stage (P = 0.027), but BRCA1 intensity was not associated with overall survival or recurrence-free survival. CONCLUSIONS: Our results demonstrate a possible association of BRCA1 expression pattern with pathologic stage, implying a potential role of BRCA1 in PDAC development and progression.
Authors: Emad A Rakha; Somaia E El-Sheikh; Mona A Kandil; Maysa E El-Sayed; Andrew R Green; Ian O Ellis Journal: Hum Pathol Date: 2008-04-08 Impact factor: 3.466
Authors: Michele M Corsini; Robert C Miller; Michael G Haddock; John H Donohue; Michael B Farnell; David M Nagorney; Aminah Jatoi; Robert R McWilliams; George P Kim; Sumita Bhatia; Matthew J Iott; Leonard L Gunderson Journal: J Clin Oncol Date: 2008-07-20 Impact factor: 44.544
Authors: Elisabeth D Coene; Catarina Gadelha; Nicholas White; Ashraf Malhas; Benjamin Thomas; Michael Shaw; David J Vaux Journal: J Cell Biol Date: 2011-01-31 Impact factor: 10.539
Authors: Charles C Hsu; Joseph M Herman; Michele M Corsini; Jordan M Winter; Matthew D Callister; Michael G Haddock; John L Cameron; Timothy M Pawlik; Richard D Schulick; Christopher L Wolfgang; Daniel A Laheru; Michael B Farnell; Michael J Swartz; Leonard L Gunderson; Robert C Miller Journal: Ann Surg Oncol Date: 2010-01-20 Impact factor: 5.344
Authors: Bin Wang; Shuhei Matsuoka; Bryan A Ballif; Dong Zhang; Agata Smogorzewska; Steven P Gygi; Stephen J Elledge Journal: Science Date: 2007-05-25 Impact factor: 47.728
Authors: Rafael Rosell; Marcin Skrzypski; Ewa Jassem; Miquel Taron; Roberta Bartolucci; Jose Javier Sanchez; Pedro Mendez; Imane Chaib; Laia Perez-Roca; Amelia Szymanowska; Witold Rzyman; Francesco Puma; Grazyna Kobierska-Gulida; Raffaele Farabi; Jacek Jassem Journal: PLoS One Date: 2007-11-07 Impact factor: 3.240
Authors: W L Santivasi; H Wang; T Wang; Q Yang; X Mo; E Brogi; B G Haffty; A B Chakravarthy; Fen Xia Journal: Br J Cancer Date: 2015-06-09 Impact factor: 7.640
Authors: Henricus J M Handgraaf; Martin C Boonstra; Arian R Van Erkel; Bert A Bonsing; Hein Putter; Cornelis J H Van De Velde; Alexander L Vahrmeijer; J Sven D Mieog Journal: Biomed Res Int Date: 2014-07-15 Impact factor: 3.411